Thus, more precisely controlled and cell-targeted experiments using novel in vivo experimental NSCLC models are warranted to better define the mechanisms of action of IKKα to clarify its tumor promoter or suppressor activity in LC development and progression. This evidence concerns the gene CHUK and laryngotracheoesophageal cleft.